Forero‐Torres, A., Leonard, J. P., Younes, A., Rosenblatt, J. D., Brice, P., Bartlett, N. L., . . . Gopal, A. K. (2009). A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma. British journal of haematology, 146(2), 171-179. https://doi.org/10.1111/j.1365-2141.2009.07740.x
Citace podle Chicago (17th ed.)Forero‐Torres, Andres, et al. "A Phase II Study of SGN‐30 (anti‐CD30 MAb) in Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma." British Journal of Haematology 146, no. 2 (2009): 171-179. https://doi.org/10.1111/j.1365-2141.2009.07740.x.
Citace podle MLA (9th ed.)Forero‐Torres, Andres, et al. "A Phase II Study of SGN‐30 (anti‐CD30 MAb) in Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma." British Journal of Haematology, vol. 146, no. 2, 2009, pp. 171-179, https://doi.org/10.1111/j.1365-2141.2009.07740.x.